FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel compound of general formula (I): , where R1 and R2, each independently, represent hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted cycloalkyl, optionally substituted aryl, etc., R3 represents hydrogen, hydroxy, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted lower alkinyl, optionally substituted lower alkoxy, etc, R4 represents hydrogen or lower alkyl, R5 represents hydrogen, lower alkyl, cycloalkyl-lower alkyl or lower alkenyl, or its pharmaceutically acceptable salt or solvate.
EFFECT: obtaining pharmaceutical composition for treatment and/or prevention of nausea, vomiting and/or constipation.
13 cl, 68 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
CRYSTALS OF 6,7-UNSATURATED-7-CARBAMOYLMORPHINANE DERIVATIVES AND METHOD OF THEIR PRODUCTION | 2011 |
|
RU2643807C1 |
CRYSTALS OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINANE DERIVATIVE, AND METHOD FOR PRODUCING SAME | 2011 |
|
RU2607084C2 |
BUPRENORPHINE ANALOGUES | 2009 |
|
RU2520222C2 |
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
METHOD FOR TREATMENT OF STATES CAUSED BY p38 KINASES AND PYRROLOTRIAZINE COMPOUNDS USED AS KINASE INHIBITORS | 2001 |
|
RU2316556C2 |
SPIROPYRAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR MODULATION OF OPIOID RECEPTOR AND METHOD FOR TREATMENT USING SUCH COMPOUNDS | 2002 |
|
RU2299883C2 |
USING SIP RECEPTOR MODULATORS IN OPHTHALMOLOGY | 2006 |
|
RU2497513C2 |
USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS | 2010 |
|
RU2600869C2 |
TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS | 2013 |
|
RU2665134C2 |
COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS | 2009 |
|
RU2481106C2 |
Authors
Dates
2010-11-10—Published
2006-05-25—Filed